CD40LG and acute lymphoblastic leukemia: Using this in vitro system, we observed an approximately 50% increase in migration when stimulating CD40LG or CD28 + CD40LG signals of BACH2OE T-ALL cells vs. PBS-treated control group in both enriched settings, whereas no significant increase in migration was observed when stimulating CD28 signaling alone (Fig. 7D).